Demystifying HbA1c testing at the point of care and the impacts of COVID-19 on patients with diabetes
23 Sep 2021
Today, many medical providers are hesitant to adopt a point-of-care testing (POCT) model for chronic disease management. During this webinar, our esteemed panel will discuss, in general, the differences between central lab and POCT, before moving the conversation into specifics about the benefits of testing for HbA1c at a point-of-care facility. In addition, our speakers will discuss the stringent quality standards in place for HbA1c POCT and the impact that a simplified user interface of these instruments can have on both the operator and patient experience. What a COVID-19 diagnosis means for a patient with diabetes and what potential health impacts could follow will also be discussed.
Following this webinar, you will be able to:
- List the key benefits of HbA1c point-of-care testing.
- Identify the quality measures HbA1c instruments must adhere to throughout the product lifecycle.
- Identify possible long-term health implications of COVID-19 on those living with Diabetes.
CE credits & certificate of attendance
SelectScience is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Attendees of this webinar are entitled to ACCENT credits from the AACC.